Business Model

To provides new formulations with Dazzle's own technology to the clients under their brand names, we develop new formulations. Moreover, we have bioequivalence studies, and clinical trials, and obtained Drug Controller General of India's (DCGI) approval for franchising and marketing of new Fixed Dose Combinations (FDCs) & molecules.

Business Model at Dazzle Healthcare